LivaNova (LIVN) Share-based Compensation (2015 - 2026)
LivaNova (LIVN) reported Share-based Compensation of $8.3 million for Q1 2026, up 6.26% on a YoY basis from $7.8 million in Q1 2025, and up 927.33% sequentially from $805000.0 in Q4 2025.
LivaNova (LIVN) Share-based Compensation (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Share-based Compensation data on file, last reported at $8.3 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 6.26% year-over-year to $8.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (down 84.39% YoY), and the FY2025 full-year result was $4.4 million, down 86.94% from the prior year.
- Share-based Compensation improved to $8.3 million in Q1 2026, from $805000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $29.4 million in Q4 2023 to a low of -$3.9 million in Q2 2025.
- A 5-year average of $7.5 million and a median of $8.2 million in 2024 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation soared 641.68% in 2024 and slumped 147.59% in 2025, its largest moves.
- Tracing LIVN's Share-based Compensation over 5 years: stood at $12.3 million in 2022, then soared by 138.35% to $29.4 million in 2023, then tumbled by 76.33% to $6.9 million in 2024, then tumbled by 88.42% to $805000.0 in 2025, then jumped by 927.33% to $8.3 million in 2026.
- Business Quant data shows LIVN's Share-based Compensation at $8.3 million in Q1 2026, $805000.0 in Q4 2025, and -$256000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 8.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.27 Mn |
| Mar 31, 2026 | 8.27 Mn |
| Dec 31, 2025 | 805,000.00 |
| Dec 31, 2025 | 805,000.00 |
| Sep 30, 2025 | -256,000.00 |
| Sep 30, 2025 | -256,000.00 |
| Jun 30, 2025 | -3.90 Mn |
| Jun 30, 2025 | -3.90 Mn |
| Mar 31, 2025 | 7.78 Mn |
| Mar 31, 2025 | 7.78 Mn |
| Dec 31, 2024 | 6.95 Mn |
| Dec 31, 2024 | 6.95 Mn |
| Sep 30, 2024 | 8.56 Mn |
| Sep 30, 2024 | 8.56 Mn |
| Jun 30, 2024 | 8.20 Mn |
| Jun 30, 2024 | 8.20 Mn |
| Mar 31, 2024 | 10.23 Mn |
| Mar 31, 2024 | 10.23 Mn |
| Dec 31, 2023 | 29.36 Mn |
| Dec 31, 2023 | 29.36 Mn |